Suchergebnisse - "Si, Zizhen"

PubPharm (28)

1

USE OF SACUBITRIL/VALSARTAN SUBSTANCE IN PREPARATION OF DRUG FOR DRUG ADDICTION AND RELAPSE

enthalten in: Europäisches Patentamt | 2024

von LIU YU | LI XIAOFANG | SI ZIZHEN | +7

2

The neuroprotective effect of LCZ696 on methamphetamine-induced cognitive impairment in mice

enthalten in: Neuroscience letters | 2024

von Qian, L. | Ruan, Y. | Gong, X. | +7

3

m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Wang, X. | Liu, Y. | Zhou, M. | +2

4

m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling

enthalten in: Journal of experimental & clinical cancer research | 2023

von Wang, X. | Liu, Y. | Zhou, M. | +2

5

Application of sacubitril valsartan substance in preparation of neurotoxicity and cognitive disorder drugs

enthalten in: Europäisches Patentamt | 2023

von LIU YU | LI XIAOFANG | QIAN LIYIN | +7

6

Application of sacubitril valsartan substance in preparation of neurotoxicity and cognitive disorder drugs

enthalten in: Europäisches Patentamt | 2023

von LIU YU | LI XIAOFANG | QIAN LIYIN | +7

7

EGCG attenuates METH self-administration and reinstatement of METH seeking in mice

enthalten in: Addiction biology | 2023

von Si, Z. | Wang, X. | Yu, Z. | +7

8

Cope with copper : From copper linked mechanisms to copper-based clinical cancer therapies

enthalten in: Cancer letters | 2023

von Wang, X. | Zhou, M. | Liu, Y. | +1

9

An unconventional cancer-promoting function of methamphetamine in hepatocellular carcinoma

enthalten in: Life science alliance | 2023

von Si, Z. | Yang, G. | Wang, X. | +7

10

Antidepressant effect of bright light therapy on patients with Alzheimer's disease and their caregivers

enthalten in: Frontiers in pharmacology | 2023

von Mei, X. | Zou, C. | Si, Z. | +4